Despite what the name suggests, Polycystic Ovary Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PCOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.
At its core, PCOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PCOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PCOS so challenging—and why understanding your unique experience matters.
So, how can the PCOS Association help?
We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PCOS—and make progress.
Here’s what you’ll find at PCOSA:
✅ Reliable, science-backed information about what PCOS is (and isn’t)
💬 Supportive communities of people who understand exactly what you’re going through
🧬 Resources for navigating fertility, metabolic health, nutrition, and more
🧠 Education for providers who want to better support their PCOS patients
🙋♀️ Advocacy to make sure PCOS is recognized, researched, and respected
No fluff. No fad cures. Just real support, grounded in evidence and compassion.
At PCOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.
pcos: Latest results from PubMed
Background/Objectives: Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder characterized by reproductive and metabolic dysfunction. Vitamin D deficiency is common in women with PCOS and is linked to adverse metabolic and reproductive outcomes. However, the role of vitamin D supplementation in managing PCOS remains unclear due to the heterogeneous evidence available. This systematic review aimed to synthesize both observational and interventional studies to assess the association...
Published on: Sat, 28 Mar 2026 06:00:00 -0400
Authors: Batoul Jaafar, Nour Chami, Mohamad Tlais, Maria Matar, Nazih Obeid, Nadia Taha, Karim El Haddad, Jessica Abou Chaaya, Sami Azar,
Polycystic ovary syndrome (PCOS) is a prevalent endocrine and metabolic disorder, primarily characterized by reproductive dysfunction, insulin resistance (IR), and long-term metabolic complications. Current first-line pharmacological treatments, including oral contraceptives, anti-androgens, and insulin sensitizers, can alleviate clinical symptoms but often fail to fully address the underlying pathophysiology, and their long-term use is frequently limited by adverse effects. Natural products,...
Published on: Sat, 28 Mar 2026 06:00:00 -0400
Authors: Siqi Liu, Rui Wang, Weili Yu, Chuanjing Shi, Xi Wang, Aifen Liu, Lei Zhang,
CONCLUSIONS: MI may have a synergistic effect at the cellular level, and the possible increase in the re-differentiation of RAIR-TC in patients treated with KIs plus MI may have great clinical relevance. The re-uptake of RAI will be evaluated as the primary endpoint, and Tg values and QoL will be evaluated as the secondary endpoints. The main limitation of this study is that we do not investigate any clinical effects. We will have to postpone the clinical analysis to a later date after the...
Published on: Sat, 28 Mar 2026 06:00:00 -0400
Authors: Carlotta Giani, Michele Russo, Paola Lapi, Maria Antonietta Profilo, Raffaella Forleo, Barbara Mazzi, Arianna Ghirri, Lisa Caresia, Alfredo Campennì, Cosimo Durante, Andrea Corsello, Riccardo Morganti, Vittorio Unfer, Rosa Maria Paragliola, Daniele Barbaro,
Background/Objectives: Although anti-Müllerian hormone (AMH) is a strong biomarker of ovarian reserve and oocyte pools, it is unknown whether high AMH levels can be a reliable predictor of oocyte quality, ovulation, and embryo quality. We aimed to determine whether there is any AMH threshold value that can be used to predict treatment success in women with clomiphene citrate (CC) resistance or failure in polycystic ovary syndrome (PCOS). Methods: This retrospective cohort study included 93...
Published on: Sat, 28 Mar 2026 06:00:00 -0400
Authors: Rifat Taner Aksoy, Gulnur Ozaksit, Gurhan Guney, Meryem Kuru Pekcan, Aytekin Tokmak,
Polycystic ovary syndrome (PCOS) is associated with impaired ovarian steroidogenesis and ovulation, which necessitates the development of effective ovulation inducers for PCOS. The aim of the study was to evaluate the effects of allosteric luteinizing hormone receptor agonist TP03 and human chorionic gonadotropin (hCG) on ovarian steroidogenesis, as well as ovulation in prepubertal female rats with dehydroepiandrosterone(DHEA)-induced PCOS. Taking into account differences in progesterone levels,...
Published on: Sat, 28 Mar 2026 06:00:00 -0400
Authors: Kira V Derkach, Alena S Pechalnova, Inna I Zorina, Irina Yu Morina, Liubov V Bayunova, Irina V Romanova, Irina V Fedorchuk, Julian R Ryzhov, Elizaveta E Chernenko, Viktor N Sorokoumov, Alexander O Shpakov,
Endometriosis and PCOS are both leading causes of female infertility, each affecting approximately 10% of reproductive-aged women worldwide. Both conditions markedly impair quality of life by affecting physical health, emotional well-being, mental health, and social functioning, and they impose a substantial economic burden through surgical treatments, assisted reproductive technologies, and work absenteeism. Insulin resistance (IR) plays a key role in the pathogenesis of both disorders by...
Published on: Sat, 28 Mar 2026 06:00:00 -0400
Authors: Noémi Varga, Rita Kis-György, Lilla Ajkay-Donáth, Zoltán István Tapody, Evelin Vágvölgyi-Sümegi, Tamás Körtési, Gábor Nagy-Grócz,
Background: For decades, the ketogenic diet has been successfully used for the treatment of obesity, metabolic syndrome, and type 2 diabetes. The mechanisms through which it affects metabolism are not fully understood, but the hormonal changes that occur during ketogenic nutrition are likely to play an important role. Objectives: To investigate the effect of the ketogenic diet on various hormones associated with obesity and the accompanying metabolic disorders in childhood. Methods: One hundred...
Published on: Sat, 28 Mar 2026 06:00:00 -0400
Authors: Ivanka N Paskaleva, Nartsis N Kaleva, Teodora D Dimcheva, Ivan S Ivanov,
Polycystic ovary syndrome (PCOS) is an endocrinological disorder characterized by weight-loss resistance. Time-restricted eating (TRE) has become a popular weight-loss tool. However, the efficacy of TRE for weight management in PCOS remains understudied. We evaluated the effectiveness of TRE compared with standard care (daily calorie restriction (CR)) and a no-intervention control in women with PCOS. Seventy-six participants were randomly assigned to one of three groups for 6 months: a 6-hour...
Published on: Sat, 28 Mar 2026 06:00:00 -0400
Authors: Sarah Corapi, Mary-Claire Runchey, Jodie Lyons, Maria Alonso de Leon, Vasiliki Pavlou, Shuhao Lin, Mark Ezpeleta, Kelsey Gabel, Lisa Tussing-Humphreys, Vanessa M Oddo, Shaina J Alexandria, Julienne Sanchez, Alaina P Vidmar, Krista A Varady, Sofia Cienfuegos,
Background/Objectives: Risk perception of future disease may play a role in supporting lifestyle change to prevent diabetes mellitus (DM) and cardiovascular disease (CVD). It is unknown how women in the postpartum period with different cardiometabolic conditions perceive their future risk of DM and CVD, and whether this perception influences engagement in a healthy lifestyle. Methods: Cross-sectional study of women who delivered in the past five years (n = 497) living in Australia. Logistic...
Published on: Fri, 27 Mar 2026 06:00:00 -0400
Authors: Amin Heidarikakolaki, Siew Lim, Maureen Makama, Mingling Chen, Melinda J Hutchesson, Cheryce L Harrison, Helen Skouteris, Helena Teede, Lisa J Moran,
Polycystic ovarian syndrome (PCOS) is a multifaceted reproductive endocrine illness marked by ovulatory dysfunction, with various causes and symptoms; it is well-accepted that hyperandrogenism and glucose metabolism disturbances significantly contribute to its progression. Our prior research demonstrated that GLP-1 receptor agonists (GLP-1RAs) could ameliorate the symptoms of PCOS mice. GLP-1RAs have the ability to control irisin expression. However, it remains ambiguous if irisin contributes to...
Published on: Fri, 27 Mar 2026 06:00:00 -0400
Authors: Yueying Yang, Chuanhao Xiong, Xiaohui Wei, Xuejiao Wang, Feijuan Kong, Ying Hu, Wen Li, Yuhang Ma, Xiaoying Ding,
CONCLUSION: Our meta-analysis, the largest one conducted to date, indicates that metformin does not significantly affect circulating gonadotropin levels in reproductive-age women with PCOS.
Published on: Fri, 27 Mar 2026 06:00:00 -0400
Authors: Robert Krysiak, Mario Simental-Mendía, Luis E Simental-Mendía,
CONCLUSION: Anxiety affects nearly one-third of Chinese women with PCOS, with prevalence shaped by age, region, and assessment methodologies. Despite alignment with global trends, regional disparities underscore the need for culturally adapted mental health interventions. Clinicians should prioritize anxiety screening in PCOS management, particularly for younger women and underserved populations.
Published on: Fri, 27 Mar 2026 06:00:00 -0400
Authors: Zhenzhen Hong, Shanshan Hong, Liying Chen, Meiling Liang, Ming Li, Jiawei Qin,
CONCLUSION: Obese patients derived the greatest benefit from nutritional intervention. Higher BMI was associated with better outcomes, particularly among younger patients and those with less ovarian enlargement. These findings support the use of personalized nutrition strategies to enhance treatment efficacy in PCOS management.
Published on: Fri, 27 Mar 2026 06:00:00 -0400
Authors: Shujun Ma, Wanliang Chen,
CONCLUSION: This study shows a high prevalence of anxiety and depression in PCOS patients, negatively impacting their QoL. Early screening for psychological symptoms is recommended to reduce severe anxiety, major depression, and suicidal incidence, thereby improving patient productivity and QoL.
Published on: Fri, 27 Mar 2026 06:00:00 -0400
Authors: Neha Gupta, Ambrish Kumar Mishra, Pushp Lata Sankhwar, Tripti Kumari,
CONCLUSION: The integration of biomedically-relevant concepts improves the interpretability of PCOS predictions while maintaining predictive performance.
Published on: Thu, 26 Mar 2026 06:00:00 -0400
Authors: Sudeepti Kulshrestha, Neeraj Kumar, Pulkit Verma, Kriti Sikri, Mayank Gangwar, Abhishek Sengupta, Suruchi Aggarwal, Priyanka Narad,